1.06529
Sodium polyphosphate
(Graham′s salt) EMPLURA®
Manufacturer: Supelco
CAS Number: 10361-03-2
Synonym(S): Sodium polyphosphate, Graham′s salt, Sodium metaphosphate
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 KG | 1.06529-1-KG | In Stock | ₹ 10,859.99 |
| 5 KG | 1.06529-5-KG | In Stock | ₹ 26,610.01 |
| 50 KG | 1.06529-50-KG | In Stock | ₹ 1,97,520.00 |
1.06529 - 1 KG
In Stock
Quantity
1
Base Price: ₹ 10,859.99
GST (18%): ₹ 1,954.798
Total Price: ₹ 12,814.788
Quality Level
200
product line
EMPLURA®
form
solid
potency
>2000 mg/kg LD50, oral (Rat)
concentration
≥68% ( P2O5, acidimetric)
pH
5.7 (20 °C, 10 g/L in H2O)
mp
550 °C
solubility
1000 g/L
density
2.5 g/cm3 at 20 °C
bulk density
1000 kg/m3
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Kerafast Lcc Sodium polyphosphate | 10361-03-2 | MFCD00131858 | -- | ₹ 24,002.15 | |
| | Sodium polyphosphate | -- | ₹ 10,859.99 - ₹ 1,97,520.00 | |
| | 10361-03-2 | Sodium metaphosphate | -- | ₹ 1,711.20 - ₹ 3,165.72 |
Related Products
Description
- Application: Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan.: This paper presents a novel approach to creating controlled-release theophylline granules using a coating made from a polyelectrolyte complex of sodium polyphosphate and chitosan. This method could significantly impact pharmaceutical formulations by improving drug release profiles and patient compliance (Kawashima et al., 1985).
- Analysis Note: Assay (acidimetric, P₂O₅): ≥ 68 %Identity: passes testChloride (Cl): ≤ 0.02 %Heavy metals (as Pb): ≤ 0.005 %Fe (Iron): ≤ 0.01 %
- Legal Information: EMPLURA is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFETY INFORMATION
Storage Class Code
13 - Non Combustible Solids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable